Cleared Traditional

K133738 - NOVOFINE PLUS 32G 4 MM

K133738 is an FDA 510(k) clearance for NOVOFINE PLUS 32G 4 MM, manufactured by Novo Nordisk, Inc.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 163-day FDA review.

K133738 · Novo Nordisk, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2014
Decision
163d
Days
Class 2
Risk

K133738 is an FDA 510(k) clearance for the NOVOFINE PLUS 32G 4 MM. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Novo Nordisk, Inc. (Plainsboro, US). The FDA issued a Cleared decision on May 21, 2014 after a review of 163 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Novo Nordisk, Inc. devices

FDA 510(k) Submission Details - K133738

510(k) Number K133738 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 09, 2013
Decision Date May 21, 2014
Days to Decision 163 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d slower than avg
Panel avg: 129d · This submission: 163d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 534
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K133738.
EASYPOINT NEEDLE
K133635 · Retractable Technologies, Inc. · Jun 2014
EWNL SAFETY SYRINGE WITH NEEDLE
K132557 · Jiamei-Un Co., Ltd. · Jun 2014
MEDI PEN NEEDLE
K131954 · Shanghai Carelife International Trading Co. , Ltd. · May 2014
CAREFINE PEN NEEDLE WITH QUINTAPOINT AND SUPERPOINT
K140568 · Facet Technologies, LLC · May 2014
INSULIN PEN NEEDLE
K133058 · Wenzhou Wuzhou Import & Export Co., Ltd. · Feb 2014
INSULIN PEN NEEDLE
K133059 · Wenzhou Beipu Science & Technology Co., Ltd. · Feb 2014